NovoCure (NVCR) EBT Growth (3y) (2017 - 2026)
Powered by 
Analysis
NovoCure (NVCR) EBT Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | -2.34% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 28.31% |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 13.94% |
| 4 | Stryker | 104.88 Bn | 101.41 Bn | 4.50 Bn | 20.27% |
| 5 | Boston Scientific | 66.35 Bn | 65.81 Bn | 3.85 Bn | 35.51% |
| 6 | Edwards Lifesciences | 49.66 Bn | 45.41 Bn | 1.35 Bn | 23.63% |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | -30.37% |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 25.85% |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | 17.92% |
| 10 | NovoCure | 1.89 Bn | 1.45 Bn | 142.48 Mn | 38.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.64% |
| Mar 31, 2026 | -10.68% |
| Dec 31, 2025 | -7.95% |
| Sep 30, 2025 | -8.63% |
| Jun 30, 2025 | -14.41% |
| Mar 31, 2025 | -129.23% |
| Dec 31, 2024 | -29.24% |
| Sep 30, 2024 | -27.02% |
| Jun 30, 2024 | -19.75% |
| Mar 31, 2024 | -126.20% |
| Dec 31, 2023 | -85.34% |
| Sep 30, 2023 | -85.36% |
| Jun 30, 2023 | -148.29% |
| Mar 31, 2023 | -106.36% |
| Dec 31, 2022 | -173.47% |
| Sep 30, 2022 | -171.50% |
| Jun 30, 2022 | -715.91% |
| Mar 31, 2022 | 33.34% |
| Dec 31, 2021 | -33.19% |
| Sep 30, 2021 | -11.28% |